Skip to main content
. 2016 Jul 7;475(1):56–61. doi: 10.1007/s11999-016-4890-4

Table 2.

Culture results from subjects with a reinfection

Joint Time to reinfection status post-Stage 2 (days) Treatment Culture results
Hip 9 Control 1. Stage 1 culture: Enterococcus faecalis Group D
2. Reinfection culture: coagulase-negative Staphylococcus
Knee 10 ABX: levofloxacin 1. Stage 1 culture: E coli
2. Reinfection culture: MRSA
Hip 16 Control 1. Stage 1 Culture: anaerobic Gram-positive cocci
2. Reinfection culture: coagulase-negative staphylococcus
Hip 21 Control 1. Stage 1 culture: Staphylococcus epidermidis, MSSA
2. Reinfection culture: MSSA
Knee 29 Control 1. Stage 1 Culture: MSSA
Reinfection culture: Serratia marcescens
Hip 36 Control 1. Stage 1 culture: MSSA
2. Reinfection culture: Escherichia coli, MSSA
Hip 40 Control 1. Stage 1 culture: MSSA
2. Reinfection culture: Streptococcus agalactiae (Group B)
Hip 72 Control 1. Stage 1 culture: MSSA
2. Reinfection culture: coagulase-negative Staphylococcus
Hip 175 Control 1. Stage 1 culture: Proteus mirabilis
2. Reinfection culture: Morganella morganii
Knee 347 ABX: cefadroxil 1. Stage 1 Culture: coagulase-negative Staphylococcus, Mycoplasma avium complex
2. Reinfection culture: Staphylococcus epidermidis
Knee 467 ABX: cefuroxime 1. Stage 1 culture: MSSA
2. Reinfection culture: MSSA
Knee 468 Control 1. Stage 1 culture: Bacterioides fragilis
2. Reinfection culture: Staphylococcus lugdunensis

ABX = antibiotics; MSSA = methicillin-susceptible Staphylococcus aureus; MRSA = methicillin-resistant S aureus.